ONDINE BIOMEDICAL INC. (OBI) — Final Results

Investor webinar replay

Replay transcript excerpt

Good afternoon, and welcome to the ONDINE BIOMEDICAL FINAL RESULTS INVESTOR PRESENTATION. Throughout this quarter presentation, investors will be in listen only mode. Questions are encouraged and can be submitted at any time by the Q and A tab situated in the right hand corner of your screen. Just simply type in your questions and press send. The company may not be in a position to answer every question it receives during the meeting itself. However, the company can review all the questions submitted today and publish responses which is appropriate to do so. Before we begin, I'd like to submit the following poll. I'd now like to hand you over to doctor Nicholas Labelle. Good afternoon to you, sir. Good afternoon. Thank you so much for the opportunity. Over to you, sir. Thank you. Welcome to investors. We are going to speak for the next twenty minutes on annuals ONDINE's annual 2023 results. You will see that this presentation is focused on growth. We are very pleased to be able to bring you what I think is a live and absolutely extraordinary set of pieces of data from last year and focusing on what will happen this year. I'd like to start by reminding investors of a dangerous fact. Imagine nine Wembley Stadiums, that's ninety thousand people in that stadium in The UK every year suffering a hospital acquired infection. That's something that occurs to you when you come into an institution for health care. You did not bring necessarily that infection with you. You acquired it from the hospital itself and no fault of the hospital or the patient or the health care workers involved. This is something that occurs as a fact and it is a consequence of bringing people together into hospitals and healthcare systems in order to receive care. But when those people come into those...